Tag: AstraZeneca COVID-19 Vaccine

  • Nigeria takes delivery of 502,600 doses of AstraZeneca vaccines

    Nigeria takes delivery of 502,600 doses of AstraZeneca vaccines

    By Joyce Remi- Babayeju

    Today Nigeria took delivery of 502,600 doses of AstraZeneca vaccines donated by the France Government to the Nigerian Government through the COVAX facility.

    Executive Director of the National Primary Health Development Agency, NPHCDA, Dr. Faisal Shuaib who received the vaccines on behalf of the Federal Government said,” The

    donation of over half a million doses of AstraZeneca to Nigeria is a demonstration of France’s confidence in Nigeria’s capability as an active and progressive partner in the global fight to end the COVID-19 pandemic.”

    Shuaib gave assurances that Nigeria’s vaccine storage facilities remain efficient and well maintained, adding that no standards are compromised in logistics requirement for effective management and utilization of all COVID-19 vaccines available in Nigeria.

    In the light of this, he noted that government has remained faithful in ensuring monitoring and accountability of vaccines.

    We track utilization of all COVID-19 vaccines in all states of the Federation and receive daily report from our Senior Supervisors and State Immunization officers who are on the field to monitor the management and administration of the vaccines in Nigeria, the NPHCDA boss said.

    “We track utilization of all COVID-19 vaccines in all states of the Federation and receive daily report from our Senior Supervisors and State Immunization officers who are on the field.”

    The French Ambassador to Nigeria, Jerome Pasquier commended the Nigerian Government in addressing COVID-19 pandemic through procurement of vaccines and effective distribution across the country.

  • COVID-19 vaccines have not shown any signs of side-effects – NGF

    COVID-19 vaccines have not shown any signs of side-effects – NGF

    The Nigeria’s Governors’ Forum on Wednesday met and deliberated on issues affecting the country, particularly on the roll out of the Covid19 vaccines and the attendant issues that have arisen since the roll out.

    Chairman of the forum and governor of Ekiti state, Kayode Fayemi, congratulated his colleagues for accepting to be vaccinated and declared that so far the vaccines have not shown any signs of side-effects as is widely rumored.

    Speaking further, the chairman also briefed his colleagues on the visit of the Committee of Vice Chancellors of States’ Universities, the activities of the Governors Spouses around Gender-Based Violence and the VAP Act calling on his colleagues to step up to the plate in support of the activities of the Nigerian Governors’ Wives Forum nationwide and the progress made with the States’ Fiscal Transparency, Accountability and Sustainability (SFTAS) project.

    Meanwhile, after the briefing by the Chairman, the NGF received a presentation from the British Deputy High Commissioner (DHC) in Lagos, Nigeria, Ben Llewellyn-Jones, on the Accelerated C-19 Economic Support (ACES) programme which is aimed at supporting Nigeria’s response to the COVID-19 crisis. The current focus of the ACES programme in Nigeria is trade facilitation through e-customs and digital jobs booster to activate the digital economy and accelerate the creation of local tech jobs in the country.

    Furthermore, following the presentation, the Forum committed to supporting a federal government-led cross-agency trade facilitation as a critical objective of the e-customs programme coordinated through the National Trade Facilitation Roadmap. Nigeria will be able to achieve the objectives of the e-customs programme (i.e., enhanced user experience, and approximately 10% growth in customs revenue to hit the US$176 billion revenue target) with a broader cross-agency scope of reform including fulfilling its Word Trade Organisation (WTO) trade facilitation agreement.

    Also, the forum also pledge commitment to encouraging digital infrastructure expansion, accelerator programmes and investment promotion to facilitate job creation in highly potential digital areas such as IT and business processing outsourcing, digital media, e-commerce, start-up innovation and smart manufacturing based
    on the comparative advantage of each State. In the light of this, State governments are encouraged to set up one-stop shops to accelerate approvals and harmonize fees for priority broadband infrastructure across the country.

    Furthermore, the NGF Secretariat will partner with the British High Commission, the Boston Consulting Group (BCG) as well as partners at the federal level on the workability of the ACES programme and the role of State governments to maximize its opportunities.

    The Forum’s COVID-19 Technical Advisory Group (CTAG) led by Professor Oyewale Tomori briefed members on the status of the COVID-19 vaccine roll out across the States including the increasing concerns of the public on the safety of Asta Zeneca vaccines. CTAG recommended that Nigeria should continue to vaccinate all eligible persons with the AstraZeneca vaccine in line with the latest WHO recommendations as available evidence, including findings from research in which some CTAG members
    are involved showing that the Astra Zeneca vaccine is safe.

    The governors reiterated their belief in the safety of the Astra Zeneca vaccines and commit to continuously encourage uptake of the vaccines by all eligible persons in their States, Governors also encourage the public to report any adverse events noticed following COVID-19 vaccination.

    Following a briefing from the Chairman/Chief Executive Officer of the National Drug Law Enforcement
    Agency (NDLEA), Buba Marwa on Managing the Drug Crisis in the country, state governors expressed commitment to supporting the logistics and operational activities of NDLEA officials in their States, as well as programmes that will promote drug use prevention in the country.

    The forum also received a presentation on the 2018 audited accounts of the Nigerian National Petroleum Corporation (NNPC) from the Facility for Oil Sector Transparency and Reform (FOSTER) led by its team lead, Mr Henry Adigun. The Forum welcomed the fiduciary risk assessment of the corporation. The additional information will support the work of State governments in engaging with the federal government to improve the governance arrangement of the oil industry.

  • France suspends AstraZeneca Covid jabs

    France suspends AstraZeneca Covid jabs

    President Emmanuel Macron said on Monday that France was suspending the use of the AstraZeneca Covid-19 vaccine, pending a review of its safety by the European Medicines Agency.

    “The decision has been made… to suspend the use of the AstraZeneca vaccine as a precaution, hoping that we can resume it quickly if the judgement of the EMA allows it,” Macron told a press conference, adding that an announcement by the EMA was expected on Tuesday afternoon.

    “We have a simple guide, to be informed by science and the competent health authorities and to do it as part of a European strategy,” he said.

    He said the suspension was, for now, effective “until tomorrow (Tuesday) afternoon” when the EMA should deliver its opinion.

    Several European countries, including Germany, Ireland, the Netherlands, have suspended usage of the shot, which was jointly developed with the University of Oxford, after reported blood clotting incidents in Europe.

    The decision reverses previous guidance from French health authorities to continue using the jab and came just a day after French Prime Minister Jean Castex had defended the vaccine.

    “At this stage, we must have confidence in this vaccine,” Castex said on Sunday.

    “If not, we’ll have delays with our vaccinations and French people will be less protected and the health crisis will last longer.”

    Speaking alongside Macron at the press conference in southwest France, Spanish Prime Minister Pedro Sanchez announced no change for Spain, but said it was important “to give a message of guarantee and safety to the whole of the European population regarding the vaccination process.”

    Macron also said that the French government would have “decisions to take” in the next few days in order to control the spread of Covid-19 cases after an uptick in cases and a rise in hospitalisations.

    “We will probably have new decisions to take in the coming days,” Macron said.

    He said the government needed to look at “the reality of the epidemic, town by town, region by region: it’s what we are doing.”

    Hospitals in the Paris region are close to capacity, with patients being transferred out of the capital region to other parts of France, while other hotspots of infection are in the north around Calais and the Cote d’Azur.

    Macron decided against a third national lockdown at the end of January, deciding instead to continue with a policy of a 6:00 pm nation-wide curfew and a partial shutdown of bars, restaurants and other social and entertainment meeting places.

    AFP

  • BREAKING: Oxford-AstraZeneca Vaccines Arrive In Nigeria

    BREAKING: Oxford-AstraZeneca Vaccines Arrive In Nigeria

    The Oxford-AstraZeneca Vaccines have arrived in the country.

    The vaccines arrived around noon on Tuesday, via an Emirates airline.

    More to follow.

  • BREAKING: NAFDAC Approves AstraZeneca COVID-19 Vaccine For Use In Nigeria

    BREAKING: NAFDAC Approves AstraZeneca COVID-19 Vaccine For Use In Nigeria

    The Oxford/AstraZeneca COVID-19 vaccine has been approved for use by the National Agency for Food and Drug Administration and Control (NAFDAC) in Nigeria.

    The vaccine was recently approved by the W.H.O for emergency use, in a press briefing, NAFDAC says it got the dossier of the vaccine a week ago, and the NAFDAC safety committee went to work immediately to evaluate its safety and efficacy for Nigerians.

    The Oxford/AstraZeneca vaccine, also known as ChAdOx1 nCoV-19, or AZD1222, is a viral vector vaccine. Scientists used an adenovirus, originally derived from chimpanzees, and modified it with the aim of training the immune system to mount a strong response against SARS-CoV-2 (the virus that causes COVID-19).

    Details shortly…